Lipid nanoparticle (LNP) formulation is an effective strategy for delivering sensitive biomolecules into cells while protecting them from degradation and improving intracellular uptake. Our RNA and protein delivery platform supports formulation of a broad range of cargo types, including RNA transcripts, mRNA, oligonucleotides, peptides, and recombinant proteins.
RNA transcript delivery
mRNA formulation
Oligo encapsulation
Protein delivery
Analytical characterization
Ready-to-transfection
Our LNP formulation workflows are designed to support encapsulation efficiency, particle uniformity, stability, and application-specific performance. This makes the platform suitable for molecule screening, intracellular delivery studies, gene expression workflows, and broader research applications where delivery performance matters.
These formulations can be delivered as ready-to-transfection products, enabling direct use in downstream cellular and functional assays.
As part of our molecular services offering, this capability bridges upstream molecule generation with downstream delivery-ready formulation, providing a clearer path from RNA or protein preparation to functional use.
Workflow goal: Each step is designed to balance encapsulation efficiency, particle quality, molecule integrity, and delivery performance for research-ready LNP formulations.
Cargo types
RNA to protein
Formulation support for multiple biomolecule classes
Platform
LNP delivery
Controlled nanoparticle formulation for intracellular delivery
Focus
Encapsulation + QC
Formulation performance supported by analytical review
Use case
Research ready
Designed for development and functional delivery studies
Need help with your delivery project? Our team can design a customized LNP formulation strategy based on your molecule type, application, and downstream performance requirements.